Amphastar Pharmaceuticals... (AMPH)
| Bid | 23.63 |
| Market Cap | 1.13B |
| Revenue (ttm) | 730.03M |
| Net Income (ttm) | 159.52M |
| EPS (ttm) | 3.06 |
| PE Ratio (ttm) | 7.8 |
| Forward PE | 6.48 |
| Analyst | Hold |
| Ask | 25.49 |
| Volume | 596,216 |
| Avg. Volume (20D) | 624,156 |
| Open | 24.82 |
| Previous Close | 25.12 |
| Day's Range | 23.69 - 24.87 |
| 52-Week Range | 22.64 - 53.96 |
| Beta | 0.78 |
About AMPH
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for AMPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · accessnewswire.com
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare ConferenceRANCHO CUCAMONGA, CA / ACCESS Newswire / April 3, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, SVP of Corp. Communication, will be parti...
1 month ago · accessnewswire.com
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance AwardRecognized for contributions to address shortage of epinephrine injection, 0.1 mg/mL syringes RANCHO CUCAMONGA, CA / ACCESS Newswire / March 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) to...
2 months ago · accessnewswire.com
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare ConferenceRANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Oper...
